Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Central Institute of Epidemiology, Moscow, Russia.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Central Institute of Epidemiology, Moscow, Russia
ClinicalTrials.gov Identifier:
NCT01059422
First received: January 28, 2010
Last updated: May 5, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)